Strut Health

About Strut Health

Strut Health has been in operation since 2020, giving it more tenure than many of its GLP-1 telehealth competitors. The platform offers compounded semaglutide and compounded tirzepatide at prices ranging from $99 to $199 per month — a straightforward and relatively affordable pricing structure. However, despite several years in the market, Strut Health has struggled to build the external validation and clinical depth that our editorial team looks for in a recommended provider.

The most notable gap in Strut Health’s profile is its complete absence from Trustpilot. With zero Trustpilot reviews, prospective patients have no independent peer feedback to reference when evaluating this provider. For a company that has been operating for over five years, this is an unusual and concerning gap. Most providers of this tenure have accumulated at least some review history, and the complete absence suggests either very low patient volume or a lack of engagement with review platforms that patients commonly rely on.

On the accreditation front, Strut Health does hold a B+ rating with the Better Business Bureau, which provides some baseline level of trust. A B+ grade indicates that the company has generally responded to complaints and maintained acceptable business practices, even if there are some unresolved issues. This BBB presence is the provider’s primary source of external validation and partially offsets the lack of patient reviews elsewhere.

The clinical offering at Strut Health is limited. The platform does not include lab testing or dietitian access, and our research indicates low ongoing support — meaning patients should not expect frequent check-ins, proactive outreach, or robust customer service after their initial consultation. For patients who are self-directed and simply want access to affordable compounded GLP-1 medications without extras, this stripped-down model may be adequate. For anyone expecting a guided experience, it will likely feel insufficient.

At its core, Strut Health is a basic, no-frills compounded medication provider with reasonable pricing and minimal support infrastructure. The B+ BBB rating provides some reassurance, but the total absence of patient reviews after five years in business is a data point that cannot be ignored. Our editorial team sees this as a provider that functions adequately for its narrow purpose but has not demonstrated the clinical quality, patient engagement, or reputation building necessary to earn a strong recommendation.

Strut Health GLP-1 Medications

At a Glance